OICS v0.3.3 class · Healthcare

Branded Prescription Drugs

ID RXB HC.PH.PHA.RXB

Discovers, develops and markets branded prescription medicines or vaccines with approved products in at least three therapeutic areas, for humans or animals; a company moves between this class and Commercial Biotech only after two consecutive annual reports on the other side.

Where it sits

Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.

Sector: HC Healthcare in the standard Medicines, medical technology and the delivery of care.
Group: HC.PH Medicines & Life Sciences Developing and making medicines, and the tools and services for it.
Industry: HC.PH.PHA Pharmaceuticals in the standard Selling approved medicines at scale.

Companies in this class

Companies whose primary class this is. The sector and industry pages and the screener count them the same way.

All companies241 Listed with filings162

Largest first Name Country

Counted by primary class: companies that are listed and have filings on FinancialFilings.

Company	Ticker	Country	Market cap	Filings
ELI LILLY & Co	LLY	United States of America	$1042.60B	4,112
JOHNSON & JOHNSON	JNJ	United States of America	$609.12B	3,358
AbbVie Inc.	ABBV	United States of America	$449.63B	2,210
Roche Holding AG	RO	Switzerland	$342.82B	243
AstraZeneca PLC	AZN	United Kingdom	$255.84B	3,687
Novartis AG	NOVN	Switzerland	$306.45B	1,488
AMGEN INC	AMGN	United States of America	$198.61B	3,164
GILEAD SCIENCES, INC.	GILD	United States of America	$169.23B	3,068
PFIZER INC	PFE	United States of America	$156.83B	6,728
BRISTOL MYERS SQUIBB CO	BMY	United States of America	$117.58B	3,627
GSK plc	GSK	United Kingdom	$114.35B	7,331
Sanofi	SAN	France	$107.11B	4,765
VERTEX PHARMACEUTICALS INC / MA	VRTX	United States of America	$112.56B	3,545
REGENERON PHARMACEUTICALS, INC.	REGN	United States of America	$81.68B	2,393
UCB	UCB	Belgium	$55.07B	1,991
Merck & Co., Inc.	MRK	United States of America	$69.40B	2,330
Zoetis Inc.	ZTS	United States of America	$32.10B	2,162
Galderma Group AG	GALD	Switzerland	$51.31B	45
Royalty Pharma plc	RPRX	United Kingdom	$32.03B	717
BIOGEN INC.	BIIB	United States of America	$26.97B	2,635
UNITED THERAPEUTICS Corp	UTHR	United States of America	$23.22B	4,252
Ipsen	IPN	France	$16.14B	1,577
Swedish Orphan Biovitrum	SOBI	Sweden	$14.61B	1,083
IONIS PHARMACEUTICALS INC	IONS	United States of America	$12.35B	2,637
Jazz Pharmaceuticals plc	JAZZ	Ireland	$15.53B	2,012
Orion Oyj	ORNAV	Finland	$11.44B	1,235
Elanco Animal Health Inc	ELAN	United States of America	$12.55B	1,111
BIOMARIN PHARMACEUTICAL INC	BMRN	United States of America	$10.92B	2,686
PTC THERAPEUTICS, INC.	PTCT	United States of America	$5.34B	1,354
Laboratorios Farmaceuticos Rovi S.A.	ROVI	Spain	$3.31B	304
LIGAND PHARMACEUTICALS INC	LGND	United States of America	$3.98B	2,071
Almirall S.A.	ALM	Spain	$3.08B	295
Ultragenyx Pharmaceutical Inc.	RARE	United States of America	$1.90B	1,186
Faes Farma S.A.	FAE	Spain	$1.67B	220
Organon & Co.	OGN	United States of America	$3.52B	508
Vetoquinol SA	VETO	France	$955.05M	366
Green Cross Corporation	006280	South Korea	$922.43M	1,485
Boryung Corporation	003850	South Korea	$463.62M	1,298
CorMedix Inc.	CRMD	United States of America	$659.00M	1,081
Vanda Pharmaceuticals Inc.	VNDA	United States of America	$351.79M	1,306
Green Cross Holdings	005250	South Korea	$294.11M	1,891
JW PHARMACEUTICAL	001060	South Korea	$376.50M	1,657
Celon Pharma S.A.	CLN	Poland	$207.42M	677
DONG-A ST CO.,LTD	170900	South Korea	$230.62M	1,257
Journey Medical Corp	DERM	United States of America	$166.03M	249
ILYANG PHARMACEUTICAL CO.,LTD	007570	South Korea	$102.19M	1,047
CHONGKUNDANG HOLDINGS CORP.	001630	South Korea	$122.39M	1,501
Assertio Holdings, Inc.	ASRT	United States of America	$124.13M	472
HANDOK Inc.	002390	South Korea	$70.52M	1,220
Fortress Biotech, Inc.	FBIO	United States of America	$101.65M	775

Companies in Pharmaceuticals → Open in the screener →

Boundaries

Other names for this activity, and where neighboring activities go instead.

Also known as

big pharmainnovative pharmaceuticalsanimal health

Not here

no approved product → CLB Clinical-Stage Biotech
approved products in one or two therapeutic areas, research-led → CMB Commercial Biotech
mostly generics, off-patent brands and over-the-counter products → GNX Generics & Consumer Health

Sent here from

Other classes in Pharmaceuticals

Generics & Consumer Health GNX HC.PH.PHA.GNX

Makes generic or biosimilar medicines, off-patent or reformulated specialty drugs, over-the-counter and consumer-health products (including vitamins, dietary supplements and medical nutrition), active ingredients, or compounded drugs, for humans or animals; a drugmaker goes by what earns most, its own patented medicines or the rest.

Also generics, OTC, API manufacturer, biosimilars

Not here makes ingredients or drugs under contract for other drug companies → CRO Contract Research & Manufacturing
Not here mostly its own patented medicines → RXB Branded Prescription Drugs or CMB Commercial Biotech

Permanent link

https://financialfilings.com/oics/RXB/

This page is keyed by the class ID RXB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.

See it in the full standard Download the standard